Recently, BCOR has been described as mutated in a subset of acute myeloid leukemia patients [40]; about 50% of which present with both BCOR and DNMT3A mutations suggesting a potential cooperation of the two genes, possibly through an epigenetic mechanisms [40]. Here, BCOR is linked to acute myeloid leukemia.